VRNO insider plans Rule 144 sale of 5,850 common shares

VRNO filed a notice of proposed sale of restricted securities under Rule 144.

Rhea-AI Filing Summary

VRNO filed a notice of proposed sale of restricted securities under Rule 144. The filing covers planned sales of 5,850 shares of common stock, par value $0.001, through broker Muriel Siebert & Co, with an indicated aggregate market value of $5,557.50. These shares relate to common stock listed for trading on OTC and Cboe Canada, with 361,815,879 shares outstanding at the time referenced.

The shares to be sold are part of a larger block of 104,571 shares of common stock acquired on 12/01/2025 through settlement of restricted stock units from the issuer as compensation for services rendered. The notice indicates an approximate sale date of 12/02/2025. By signing the notice, the seller represents that they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What type of transaction does VRNO disclose in this Form 144?

The filing discloses a proposed Rule 144 sale of restricted or control securities of VRNO’s common stock, par value $0.001, by a person associated with the issuer.

How many VRNO shares are planned to be sold and what is their market value?

The notice covers a planned sale of 5,850 shares of VRNO common stock with an indicated aggregate market value of $5,557.50.

When were the VRNO shares acquired and how were they obtained?

The underlying common stock was acquired on 12/01/2025 through settlement of restricted stock units from the issuer as compensation for services rendered, in a total amount of 104,571 shares.

When is the sale of VRNO shares expected to occur and through which broker?

The approximate sale date listed is 12/02/2025, and the broker named is Muriel Siebert & Co, based in Jersey City, New York.

On which markets are the VRNO shares referenced in this notice traded?

The common stock referenced in the notice is associated with trading on OTC and Cboe Canada.

How many VRNO shares were outstanding at the time referenced in the Form 144?

The securities information section reports 361,815,879 shares of common stock outstanding for VRNO at the time referenced in the notice.

What representation does the seller make about VRNO’s information in this Form 144?

By signing the notice, the seller represents that they do not know of any material adverse information about VRNO’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/02/2025 - 06:08 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001981213
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Verano Holdings Corp.
SEC File Number	000-56342
Address of Issuer	224 W HILL STREET SUITE 400 CHICAGO ILLINOIS 60610
Phone	312-265-0730
Name of Person for Whose Account the Securities are To Be Sold	Kalesnik Laura Marie
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock, par value $0.001	Muriel Siebert & Co 15 Exchange Place, 8th Floor Jersey City NY 07302	5850	5557.50	361815879	12/02/2025	OTC; Cboe Canada

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock, par value $0.001	12/01/2025	Settlement of Restricted Stock Units	Issuer			104571	12/01/2025	Compensation for Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Represents the sale of Common Stock pursuant to a plan intended to comply with Rule 10b5-1(c), previously entered into on September 10, 2025, at which time the selling person was not aware of material nonpublic information, and does not represent a discretionary sale by the Reporting Person.
Date of Notice	12/02/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Kevan Fisher, Attorney-in-Fact
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)